All In MedTech

FDA Clearance Tracker · P200015-S009

Edwards SAPIEN 3 Transcatheter Heart Valve System with Edwards Commander Delivery System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 16, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 16, 2021

Approved

Time to decision

28 days

Received Mar 19, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

The decision

FDA number
P200015-S009
Device name
Edwards SAPIEN 3 Transcatheter Heart Valve System with Edwards Commander Delivery System
Applicant location
Irvine, CA
Received
Mar 19, 2021
Decided
Apr 16, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P200015

Device type

Every decision under product code NPV

FDA's approval statement

As written in FDA's record.

Approval for the Statistical Analysis Plan (SAP) for the COMPASSION S3 Post-Approval Study.

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.